Torres, T.Fernandes, I.Costa, V:Selores, M.2011-11-202011-11-202011Acta Dermatovenerol Alp Panonica Adriat. 2011;20(1):23-5.1318-4458http://hdl.handle.net/10400.16/868The authors decided to evaluate the possible use of methyl-aminolevulinate photodynamic therapy (MAL-PDT) as adjunctive therapy for morpheaform basal cell carcinoma prior to standard surgical excision in order to reduce tumor size and volume and to facilitate surgical treatment. It was observed that MAL-PDT may be an option as an adjunctive therapy prior to standard surgical excision of morpheaform basal cell carcinoma, leading to less invasive surgeryengphotodynamic therapymorpheaform basal cell carcinomaadjunctive therapyjournal article